col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


103 Ergebisse       Seite 1

 [1] 
Elsevier: Atherosclerosis
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―03 THE FIRST REPORT OF 2:1 ATRIOVENTRICULAR BLOCK FOLLOWING COVID-19 VACCINATION Seyyed Shamsadin Athari, Entezar Mehrabi Nasab
2 [GO] 2024―Dez―03 NF-κB1,TNF,VEGF A&VEGF B IN A MOUSE MODEL OF SARS-COV-2 INFECTION Wael Hafez, Asrar Rashid, Feras Al-Obeidat, Nouran Hamza, Muneir Gador, Mohammed Abdelmoneim M. Othman, et al. (+6)
3 [GO] 2024―Aug―15 Obesity and covid-19. Insulin resistance, hyperglycemia and severity of covid-19 are associated with worse outcomes in the obese. University hospital of Ioannina covid-19 registry, NCT05534074 Angelos Liontos, Diamantina Lymperatou, Dimitrios Biros, Eleni Pargana, Nikolaos-Gavriel Kolios, Maria Nasiou, et al. (+14)
4 [GO] 2024―Aug―15 Two types of inflammation: COVID-19 and acute myocardial infarction. What is the difference? Anna Kalinskaya, Daria Vorobyeva, Elena Maryukhnich, Alexandra Anisimova, Oxana Ivanova, George Rusakovich, Elena Vasilieva
5 [GO] 2024―Aug―15 Plasma levels of apolipoproteins A1/B and oxLDL in patients with covid-19 Liubov Sokolova, Victor Pushkarev, Anastasiia Sokolova, Volodymir Pushkarev, Olena Kovzun, Mycola Tronko
6 [GO] 2024―Aug―15 Influence of angiotensin receptor-neprilysin inhibitor on biochemical markers in patients with chronic heart failure after COVID-19 Guzal Sabirova, Jamol Uzokov, Adiba Usmonxudjaeva, Nikita Demin, Gulruhsor Jumaeva
7 [GO] 2024―Aug―15 Mathematical simulation of COVID-19 infection risk factor in cardiovascular diabetic patients. The effect of metformin and the act of viral volume Evangelos Mylonas, Michael Filippakis, Christina Mamareli, Jane Anastassopoulou, Ioannis Mamarelis, Theofile Theophanides
8 [GO] 2024―Aug―15 Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074 Angelos Liontos, Valentini Samanidou, Dimitrios Biros, Konstantina-Helen Tsarapatsani, Rafail Mantzaras, Eleni Pargana, et al. (+12)
9 [GO] 2024―Aug―15 The impact of COVID-19 on left ventricular remodeling and systolic function, cerebral blood flow and microembolic signals burden in patients with stable coronary artery disease Vasyl Netiazhenko, Serhii Mostovyi, Olga Safonova, Vitalii Gurianov, Kyrylo Mikhaliev
10 [GO] 2024―Aug―15 Galectin- 3 (Gal-3) in different forms of heart failure (HF) in COVID-19 patients Nana Egiashvili, Levani Ratiani, Nona Kakauridze
11 [GO] 2024―Aug―15 Acute arterial occlusion in COVID-19 patients - what have we learned Kristian Karlović, Gojko Bogdan, Pejana Rastović, Martin Kajić
12 [GO] 2024―Aug―15 Prevalence of pulmonary embolism among post COVID-19 patients underwent CT pulmonary angiography, in comparison to others Dimitrios Bouras Soulimas, Georgios Chatzis, Maria Vlachopoulou, Stamatia Katelani, Eutichia Kalogiannaki, Christos Sotopoulos, et al. (+6)
13 [GO] 2024―Aug―15 Peculiarities of proteomics and hemostasis in post COVID-19 patients with acute myocardial infarction Antonina Elizarova, Anna Kalinskaya, Alexandra Anisimova, Elena Maryukhnich, Oxana Ivanova, Daria Vorobyeva, et al. (+5)
14 [GO] 2024―Aug―15 Disease severity and inflammation in COVID-19 patients with venous thromboembolism is associated to worse outcomes the university hospital of Ioannina COVID-19 Registry, NCT05534074 Angelos Liontos, Dimitrios Biros, Konstantina-Helen Tsarapatsani, Rafail Mantzaras, Maria Nasiou, Christiana Pappa, et al. (+13)
15 [GO] 2024―Aug―15 Impact of in-hospital COVID-19 quarantine policy on the quality of care of hyperacute stroke: A single-center study Youngduck Cho, Sung-Jun Park
16 [GO] 2024―Aug―15 Identification of a molecular signature associated with covid-19 severity using a comprehensive 1H-NMR serum metabolomics profiling strategy Nuria Amigo, Neus Martínez-Micaelo, Maria Velasco, Maria Luisa Casas, Xavier Correig, Carlos Guijarro
17 [GO] 2024―Aug―15 The dynamics of clinical, laboratory and instrumental parameters in hypertensive patients with and without obesity who underwent COVID-19-associated pneumonia Tatiana Petelina, Natalia Musikhina, Valeria Garanina, Ksenia Avdeeva, Liana Valeeva, Lyidmila Gapon, Elena Kalyuzhnaya
18 [GO] 2024―Aug―15 Real-world estimation of cardiovascular risk, control of blood pressure and LDL-cholesterol: Results of two epidemiological studies in Romania, conducted during pandemic (snapshot-1) and post-pandemic (snapshot-2) Andrea-Olivia Ciobanu, Oana Vittos, Bogdan-Mihai Dolofan, Nicoleta Trambitas, Rodica Tanasescu, Cristian Guja, Dragos Vinereanu
19 [GO] 2023―Aug―29 Endothelial function and arterial stiffness of patients with cardiovascular diseases hospitalized due to COVID-19 C. Araújo, A. Dornelas De Andrade, J. Fernandes, D. Caetano, A.E. Barros, J. Souza, et al. (+5)
20 [GO] 2023―Aug―29 Endothelial functional status in patients with atherosclerotic coronary artery disease and type 2 diabetes mellitus after COVID-19 S. Ubaydullaev, A. Alyavi, J. Uzokov
21 [GO] 2023―Aug―29 Indicators of myocardial electrical instability during high-dose atorvastatin therapy in patients after acute myocardial infarction in combination with COVID-19 V. Oleynikov, Y. Barmenkova, A. Tonkoglaz, M. Lukyanova, I. Avdeeva
22 [GO] 2023―Aug―29 The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19 V. Bianconi, M. Mannarino, E. Cosentini, F. Figorilli, C. Colangelo, G. Cellini, et al. (+4)
23 [GO] 2023―Aug―29 Intracardiac hemodynamics and heart rate variability in stable coronary artery disease patients with concomitant COVID-19 V. Netiazhenko, S. Mostovyi, O. Safonova, K. Mikhaliev
24 [GO] 2023―Aug―29 Thromboinflammation prevention in COVID-19 hospitalised patients: A retrospective study G. Chatzis, M. Vlachopoulou, K. Koronios, E. Stratigaki, D. Fellouri, G. Aleiferis, et al. (+4)
25 [GO] 2023―Aug―29 Effect of polypill therapy on lipid profile and arterial stiffness in patients with dyslipidemia, arterial hypertension and COVID-19 in different age groups V. Oleynikov, L. Salyamova, K. Pavlenko, M. Lukyanova, N. Borisova
26 [GO] 2023―Aug―29 Low high-density lipoprotein level is a risk factor for postvaccination COVID-19 in hemodialysis patients N. Stepanova, A. Rysyev, L. Snisar
27 [GO] 2023―Aug―29 Cardiovascular disease (CVD) and COVID-19 infection: A deadly synergism J. Hamilton, N. Huang, M. Saeed, M. Sagar, A. Zheng
28 [GO] 2023―Aug―29 Effects of COVID-19 severity on the atherosclerotic risk POS-recovery: Relation between inflammation and lipoproteins R. Conde, R. Gil-Redondo, M. Bizkarguenaga, C. Bruzzone, A. Laín, B. González-Valle, et al. (+5)
29 [GO] 2023―Aug―29 Characteristics of acute coronary syndrome during COVID 19 pandemic L. Ferhatbegovic, B. Pojskic
30 [GO] 2022―Aug―30 Cardiovascular outcomes of COVID-19 disease at the elderly A. Capisizu, R. Mihalache, A. Capisizu, M. Roman, S.M. Aurelian
31 [GO] 2022―Aug―30 Thromboembolic complications in COVID-19 clinical case A. Capisizu, S.A. Capisizu, D. Cuzino, A. Zamfirescu
32 [GO] 2022―Aug―30 Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study G. Photiou, N. Middleton, D.B. Panagiotakos, A. Panayiotou
33 [GO] 2022―Aug―30 Characteristic of patients with COVID-19 and myocardial infarction N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov
34 [GO] 2022―Aug―30 Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence A.G. L'Huillier, S. Pagano, S. Baggio, B. Meyer, D.O. Andrey, M. Nehme, et al. (+8)
35 [GO] 2022―Aug―30 COVID-19 and cardiovascular system: Not only heart but also vascular. The effects of the infection on arterial stiffness A. Maloberti, E. Gualini, S. Scarpellini, M. Algeri, M. Biolcati, E. Grasso, et al. (+3)
36 [GO] 2022―Aug―30 Coronary artery disease is an independent risk factor for in-hospital COVID-19 all-cause mortality A.V. Shalaeva, K.T. Mirakhmedova, N.A. Dadabaeva, S.S. Egamova, U.S. Abdullaev, A.K. Shadmanov
37 [GO] 2022―Aug―30 Flow-mediated dilation of the brachial artery in patients with obesity after COVID-19 O. Pogorelova, I.O. Kokaeva, M. Tripoten, Y. Zhernakova, T. Balakhonova
38 [GO] 2022―Aug―30 Apolipoproteins A1 level in the plasma of patients with COVID-19 L.K. Sokolova, J.B. Belchina, V.M. Pushkarev, O.I. Kovzun, V.V. Pushkarev, M.D. Tronko
39 [GO] 2022―Aug―30 Cardiovascular risk factors in patients with primary myocardial infarction in combination with COVID-19 V. Oleynikov, L. Salyamova, K. Korenkova, K. Polezhaeva, N. Donetskaya, A. Babina
40 [GO] 2022―Aug―30 Features of indicators of central pressure and stiffness in patients with primary myocardial infarction in combination with COVID-19 V. Oleynikov, L. Salyamova, M. Lukyanova, K. Korenkova, A. Kulyutsin
41 [GO] 2022―Aug―30 The possible role of TyG index and TRG/HDL, CRP/HDL, NEUTROPHILS/HDL lymphocytes/HDL ratios in disease severity and outcomes in COVID-19 hospitalized patients with arterial hypertension A. Liontos, D. Biros, A. Papathanasiou, O. Milionis, M. Nasiou, E. Pargana, et al. (+15)
42 [GO] 2022―Aug―30 FT-IR spectroscopic study of atheromatic plaque formation and the risk of COVID-19 mortality of patients with cardiovascular diseases. A mathematical simulation approach I. Mamarelis, J. Anastassopoulou, E. Mylonas, V. Mamareli, K. Spiliopoulos, T. Theophanides
43 [GO] 2022―Aug―30 Impact of COVID-19 outbreak in stemi patients in the regional emergency center in Seoul, Korea Y. Cho, Y. Yoon, S. Park
44 [GO] 2022―Aug―30 Adaptation of a new cardiac rehabilitation program in times of COVID-19 pandemic M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce
45 [GO] 2022―Aug―30 Medical care to patients with acute myocardial infarction during COVID-19 pandemic N.A. Koriagina, V.S. Koriagin, K.V. Prokhorov, G.N. Spasenkov
46 [GO] 2022―Aug―30 Acute coronary syndrome outside and during the COVID-19 pandemic N.A. Koriagina, V.S. Koriagin, A.I. Maltcev, S.G. Shulkina
47 [GO] 2022―Aug―30 The management of patients with chronic cardiovascular therapies in Lombardy region: The impact of the COVID-19 pandemic F. Galimberti, E. Olmastroni, A.L. Catapano, E. Tragni, M. Casula
48 [GO] 2022―Aug―30 New semi-presential modality in cardiac rehabilitation due to COVID-19 pandemic. What results have we obtained? M. A. Martin Toro, M. S. Herruzo Rojas, E. J. Martinez De Morentin Laurenz, S. Blasco Turrion, F. J. Morales Ponce
49 [GO] 2022―Aug―30 Risk factors of deep vein thrombosis in COVID-19 patients M. Tripoten, O. Pogorelova, T. Balakhonova
50 [GO] 2022―Aug―30 Uncontrolled vs controlled type 2 diabetes and increased risk of 30-days all-cause mortality in COVID-19 patients E.V. Shalaeva, M.I. Shamsutdinova, F.L. Azizova, O.R. Teshaev, S.A. Boymuradov, H. Saner
51 [GO] 2022―Aug―30 Significance of LDL-C in appearance of myocardial infarction in COVID-19 patients in Bosnian population - One center experience L. (Pojskic) Ferhatbegovic, B. Pojskic, D. Mrsic
52 [GO] 2022―Aug―30 Laboratory findings and clinical outcomes of 681 COVID-19 patients with dyslipidemia requiring hospitalization A. Liontos, D. Biros, O. Milionis, S. Tsourlos, L. Athanasiou, A. Papathanasiou, et al. (+20)
53 [GO] 2022―Aug―30 Thrombotic and thromboembolic events in COVID-19 patients: Association with clinical presentation, progression and laboratory findings. Data analysis of a 681 patient cohort A. Liontos, D. Biros, S. Tsourlos, L. Athanasiou, O. Milionis, A. Papathanasiou, et al. (+23)
54 [GO] 2022―Aug―30 Baseline high-density lipoprotein level is associated with COVID-19 pneumonia severity in hemodialysis patients N. Stepanova, A. Rysyev, O. Rusyn, T. Ostapenko, L. Snisar, S. Rusanov
55 [GO] 2022―Aug―30 Modifiable and non-modifiable cardiovascular risk factors on sensory disorder of smell and taste in COVID-19 population A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, E. Klouras, et al. (+6)
56 [GO] 2022―Aug―30 Association of cardiovascular risk factors and olfactory or taste dysfunction in COVID-19 population. Data from an academic center in Greece A. Liontos, A. Zarachi, O. Milionis, P. Vasileios, I. Komnos, A. Lianou, et al. (+6)
57 [GO] 2022―Aug―30 Coronary atherosclerosis in COVID-19 survivors: Association with cardiac injury and function at 6 weeks R.A. Groen, M.A. De Graaf, W.J. Jukema, M.J. Schalij, J.L. Stöger, J.J.M. Geelhoed, M.L. Antoni
58 [GO] 2022―Aug―30 COVID-19 vaccination associated severe immune thrombocytopenia: A case report M. Mousdi, S. Pegka, M. Skouteli, K. Trachana, G. Chatzis, S. Bakidis
59 [GO] 2022―Aug―30 Relationship between biomarkers and global myocardial strain parameters in patients with cardiovascular pathology and metabolic disorders after COVID-19-associated pneumonia T. Petelina, N. Musikhina, E. Yaroslavskaya, E. Gorbatenko, N. Galeeva, K. Avdeeva, et al. (+2)
60 [GO] 2022―Aug―30 Coronavirus at the heart center of Puerto Rico incidence-death: The role of genetics C.M. Diaz, L.E. Barreto, P.I. Altieri, H.L. Banchs, N. Villar, F.J. Colón
61 [GO] 2022―Aug―30 Maternal fructose intake reinforces the effects of a Western-type diet in promoting SARS-CoV-2 cell entry factors in male offspring C. Donis, E. Fauste, M. Pérez, L. Rodríguez, S. Rodrigo, J.J. Álvarez-Millán, et al. (+3)
62 [GO] 2022―Aug―30 Atrial fibrillation incidence in SARS-CoV-2 infected patients: Predictors and relationship with in-hospital mortality A. Maloberti, C. Giannattasio, P. Rebora, G. Occhino, N. Ughi, J. Rizzo, et al. (+11)
63 [GO] 2022―Aug―30 Lipoprotein(a) and SARS-CoV-2 infections: Risk for ischemic heart disease and thromboembolic events S. Di Maio, C. Lamina, S. Coassin, L. Forer, R. Würzner, S. Schönherr, F. Kronenberg
64 [GO] 2022―Aug―30 Direct and indirect effects of SARS-CoV-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation R. Scicali, V. Ferrara, S. Piro, F. Purrello, A. Di Pino
65 [GO] 2022―Aug―30 A mouse model of arterial endothelial cell-specific inflammation reveals pathways of endothelial dysfunction and the simultaneous upregulation of ACE2, the receptor of SARS-CoV2 J.A. Schmid, M. Mussbacher, J. Basílio, M. Salzmann
66 [GO] 2022―Aug―02 Lipoprotein(a) during COVID-19 hospitalization: Thrombosis, inflammation, and mortality Morten Kaltoft, Kathrine Glavind, Sune Fallgaard Nielsen, Anne Langsted, Kasper Karmark Iversen, Børge Grønne Nordestgaard, Pia Rørbæk Kamstrup
67 [GO] 2022―Mrz―12 Lipoprotein(a) in COVID-19: Genetics and inflammation collide Martina Montagnana, Giuseppe Lippi
68 [GO] 2021―Dez―22 Pre-infection HDL-cholesterol levels and mortality among elderly patients infected with SARS-CoV-2 Jose M. Mostaza, Miguel A. Salinero-Fort, Juan Cardenas-Valladolid, Fernando Rodriguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, et al. (+3)
69 [GO] 2021―Dez―21 Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study Nick S. Nurmohamed, Didier Collard, Laurens F. Reeskamp, Yannick Kaiser, Jeffrey Kroon, Tycho R. Tromp, et al. (+9)
70 [GO] 2021―Nov―13 Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality Michael Feher, Mark Joy, Neil Munro, William Hinton, John Williams, Simon de Lusignan
71 [GO] 2021―Sep―15 Reply to: “Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead” Monica Verdoia, Giuseppe De Luca
72 [GO] 2021―Sep―03 Dynamic of lipoprotein responses in patients with severe COVID-19 A. Leonard, A. Doolan, G. Boran, D. Burke, T. Moulton, M. Donnelly, et al. (+2)
73 [GO] 2021―Sep―03 Hepatic transcriptional effects of simvastatin and the possible impact on COVID-19 O. Ahmed, A.K. Mukarram, C. Pirazzini, E. Elena Marasco, M. Pedrelli, M.E. Minniti, et al. (+8)
74 [GO] 2021―Sep―03 Patients with symptomatic coronary artery disease are at the increased risk of worsening the course of the disease after recovery from COVID-19 A.V. Shalaeva, K.T. Mirakhmedova, A.K. Shadmanov
75 [GO] 2021―Sep―03 SARS-COV-2 (COVID-19) anosmia in patients with obesity: A retrospective study N. Sarantis, M. Vlachopoulou, G. Chatzis
76 [GO] 2021―Sep―03 Retrospective study of patients admitted form March to January 2021 by COVID-19 in hospital Infanta Elena (Huelva). M.E. Mansilla Rodríguez, A. Fulgencio Delgado, G. Mariscal Vázquez, J.I. Ramos Clemente Romero
77 [GO] 2021―Sep―03 presentation of SARS-CoV-2 (COVID-19 in patients with congestive heart failure. A Retrospective study G. Chatzis, M. Vlachopoulou, A.E. Gawish, A.A.A. Alslmy, M.A. Karish, N.K. Aljarbaa, et al. (+10)
78 [GO] 2021―Sep―03 Can plasma lipid levels be correlated to severe COVID-19 infection? O.A. Uyaroğlu, M. Özdede, N. Çalık Başaran, B. Köylü, T.K. Şahin, L. Özışık, et al. (+2)
79 [GO] 2021―Sep―03 COVID-19 pandemic and triggered acute myocardial infarction and out-of-hospital cardiac arrest in non-infected individuals A. Hammoudeh, E. Mdanat, R. Almoheisen, M. Jabari, H. Janabi, R. Ibdah
80 [GO] 2021―Sep―03 How the way we live will look different in the wake of the COVID-19 pandemic? A survey in Greece D.B. Panagiotakos, R. Kosti, C. Vassou, C. Pitsavos
81 [GO] 2021―Sep―03 COVID-19-related quarantine effect on dietary habits in a northern italian rural population: Data from the BRISIGHELLA heart study A.F.G. Cicero, F. Fogacci, M. Giovannini, M. Mezzadri, E. Grandi, C. Borghi
82 [GO] 2021―Sep―03 Statin therapy and COVID-19: A retrospective cohort study in a province of Northern Italy S. Greco, F. Luciani, E. Giorgini, A. D'Amuri, M. Lopreiato, V. Fortunato, et al. (+4)
83 [GO] 2021―Sep―03 Diabetes and overweight/obesity are independent, non-additive, risk factors for the in-hospital severity of COVID-19: An international, multi-center retrospective analysis D.K. Longmore, J.E. Miller, S. Bekkering, C. Saner, E. Mifsud, Y. Zhu, et al. (+5)
84 [GO] 2021―Sep―03 Cholesterol and COVID-19: Findings from lipid profile of patients with SARS-COV-2 infection. I. Rossi, D. D'Ardes, B. Bucciarelli, M. Allegra, M.T. Guagnano, F. Santilli, et al. (+5)
85 [GO] 2021―Sep―03 Development features of coronavirus disease complications in patients with coronary heart disease N.M. Nurillaeva, M.M. Makhkamova, K.B. Omarov
86 [GO] 2021―Sep―03 Creation of a transgenic mouse model to study the SARS-CoV-2 effect on the pathogenesis of atherosclerosis M. Kubekina, L. Ilchuk, A. Bruter, A. Deykin
87 [GO] 2021―Sep―03 Acute myocardial infarction after laboratory confirmed SARS-CoV-2 infection J. Ena, M. Bou-Collado, M.D. Reyes-Jara, R. Afonso-Carrillo, R. Mulet, V. Valls
88 [GO] 2021―Sep―03 SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 S. Pagano, S. Yery, B. Meyer, C. Juillard, N. Suh, C. Le Terrier, et al. (+15)
89 [GO] 2021―Sep―03 How controlled were dyslipidemias in a year of pandemic? E.M.M. Silva, B. Marques, C. Cunha, R. Ferreira, C. Bello, C. Limbert, et al. (+2)
90 [GO] 2021―Aug―12 Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead Marco Zuin, Gianluca Rigatelli, Giovanni Zuliani, Loris Roncon
91 [GO] 2021―Jul―21 Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry Giuseppe De Luca, Niels Debel, Miha Cercek, Lisette Okkels Jensen, Marija Vavlukis, Lucian Calmac, et al. (+75)
92 [GO] 2021―Jun―25 Statin use and mortality in COVID-19 patients: Updated systematic review and meta-analysis Anastasios Kollias, Konstantinos G. Kyriakoulis, Ioannis G. Kyriakoulis, Thomas Nitsotolis, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos
93 [GO] 2021―Mai―27 Teaching an old dog new tricks: The prognostic role of CACS in hospitalized COVID-19 patients Ahmed Ibrahim Ahmed, Paolo Raggi, Mouaz H. Al-Mallah
94 [GO] 2021―Apr―17 The prognostic role of cardiac troponin in hospitalized COVID-19 patients Ibrahim Halil Tanboğa, Uğur Canpolat, Elif Hande Özcan Çetin, Harun Kundi, Sema Turan, Osman Celik, et al. (+5)
95 [GO] 2021―Apr―07 Impact of clinical and subclinical coronary artery disease as assessed by coronary artery calcium in COVID-19 Alessandra Scoccia, Guglielmo Gallone, Alberto Cereda, Anna Palmisano, Davide Vignale, Riccardo Leone, et al. (+32)
96 [GO] 2021―Feb―15 Coronavirus disease-19: The multi-level, multi-faceted vasculopathy Thiago Quinaglia, Mahsima Shabani, Ikaro Breder, Harry A. Silber, João A.C. Lima, Andrei C. Sposito
97 [GO] 2021―Jan―24 Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment Alpo Vuorio, Frederick Raal, Markku Kaste, Petri T. Kovanen
98 [GO] 2020―Dez―23 Patient referrals audit: Evaluation of local cardiovascular risk clinic referrals to help aid patient triage during COVID-19 A.H. Boal, C.M. Ross
99 [GO] 2020―Dez―23 Obesity is a major risk factor for severe COVID-19 illness H.L. Li, B.M. Cheung
100 [GO] 2020―Okt―14 Endothelial dysfunction in COVID-19: Current findings and therapeutic implications Matthias P. Nägele, Bernhard Haubner, Felix C. Tanner, Frank Ruschitzka, Andreas J. Flammer
101 [GO] 2020―Sep―15 Managing hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UK Zohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, et al. (+15)
102 [GO] 2020―Jun―16 Management of acute myocardial injury in patients with confirmed or suspected COVID-19 Yiannis S. Chatzizisis, Ganesh Gajanan, Deepak L. Bhatt, George Dangas, Thomas Porter
103 [GO] 2020―Mai―28 SARS-CoV-2 as a protective factor for cardiovascular mortality? Frédéric Dutheil, Marion Trousselard, Valentin Navel
 [1] 

103 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec